Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

Detalles Bibliográficos
Autores principales: Gu, Chunyan, Wang, Yajun, Zhang, Lulin, Qiao, Li, Sun, Shanliang, Shao, Miaomiao, Tang, Xiaozhu, Ding, Pinggang, Tang, Chao, Cao, Yuhao, Zhou, Yanyan, Guo, Mengjie, Wei, Rongfang, Li, Nianguang, Xiao, Yibei, Duan, Jinao, Yang, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114437/
https://www.ncbi.nlm.nih.gov/pubmed/37072818
http://dx.doi.org/10.1186/s13046-023-02672-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114437/
https://www.ncbi.nlm.nih.gov/pubmed/37072818
http://dx.doi.org/10.1186/s13046-023-02672-7

Ejemplares similares